Covid-19 induced worsening of glomerular diseases
Covid-19 induced worsening of glomerular diseases
批准号:
10655140
负责人:
Camille Emilie Adeline Mace
金额:
$34.76万
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-03-15 至 2027-12-31
关键词:
2019-nCoVAcuteAcute Renal Failure with Renal Papillary NecrosisAdriamycin PFSAlbuminuriaAnimal ModelAntibodiesCOVID-19COVID-19 complicationsCOVID-19 cytokine stormCOVID-19 diagnosisCOVID-19 impactCOVID-19 patientCOVID-19 riskCOVID-19 treatmentCXCL5 geneChronic Kidney FailureClinical ResearchComplexCreatinineDataDiabetes MellitusDiabetic NephropathyDiseaseDisease OutcomeDoseEndotheliumFocal and Segmental GlomerulosclerosisGoalsHeart InjuriesHistologyHospitalizationHumanHypersensitivityIL-13Ralpha1IL8RB geneInfectionInflammatoryInjectionsInjuryInjury to KidneyInterleukin-13Interleukin-4KidneyKidney DiseasesKnock-outMediatingModelingMorphologyMusObesityPathway interactionsPatientsPersonsPlasmaProteinsProteinuriaRattusRenal functionRenal glomerular diseaseRespiratory Tract InfectionsRisk FactorsRodentRoleSARS-CoV-2 infectionSepsisSerumSignal PathwaySystemSystemic diseaseTNF geneTNFRSF1A geneTherapeuticVEGFA geneWorld Health Organizationacute liver injurychemokinecoronavirus diseasecytokinecytokine release syndromedb/db mousediabetic ratimprovedimproved outcomemortalitynovel therapeutic interventionolder patientpandemic diseasepodocytepost SARS-CoV-2 infectionpreventreceptorsevere COVID-19tumor
中文摘要
摘要/摘要(最多30行):
英文摘要
Summary / Abstract (max 30 lines):
SARS-CoV-2 is a respiratory tract infection associated with an extensive cytokine storm. Focal and segmental
glomerulosclerosis (FSGS) and diabetic nephropathy (DN) are established risk factors for COVID-19
complications. Whereas both diseases can be exacerbated under cytokine storm conditions, the effect of COVID-
19 associated cytokine storm on the course of established FSGS and DN is not clear. We expect FSGS and DN
to be worsened after COVID-19 infection. Based on human observational data, we generated multiple cytokine
cocktails to mimic the COVID-19 cytokine storm, and showed that they cause multisystem injury when injected
in rodents at high dose (severe COVID-19 in patients), and worsen kidney injury at low dose (mild COVID-19 in
patients). Studying the effect of COVID-19 cytokine storm in animal models of glomerular disease will allow a
better understanding of the impact of COVID-19 on patient with existing disorders. Furthermore, neutralizing the
cytokine storm could potentially improve the outcome of hospitalized COVID-19 patients and prevent worsening
of kidney function by using a combination of receptor blockage and cytokine depletion
In Specific Aim 1, the applicant will study worsening of glomerular disease and chronic kidney disease due to
FSGS and DN after induction of COVID-19 like cytokine storm.
In Specific Aim 2, the applicant will assess the impact of allergy pathway cytokines IL-4 and IL-13, and
inflammatory pathway cytokine TNF-α, and chemokine CXCL5 released during COVID-19 respiratory infection
on pre-existing glomerular diseases.
In Specific Aim 3, the applicant will treat COVID-19 related worsening of glomerular disease and chronic kidney
disease FSGS and DN by depletion or blockage of the cytokine storm.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金